Linden Thomas Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.29M | Buy |
27,798
+1,056
| +4% | +$48.9K | 0.14% | 230 |
|
|
2025
Q1 | $1.63M | Buy |
26,742
+639
| +2% | +$39K | 0.21% | 175 |
|
|
2024
Q4 | $1.48M | Sell |
26,103
-509
| -2% | -$28.8K | 0.19% | 203 |
|
|
2024
Q3 | $1.38M | Sell |
26,612
-266
| -1% | -$13.8K | 0.19% | 215 |
|
|
2024
Q2 | $1.12M | Sell |
26,878
-15,660
| -37% | -$650K | 0.17% | 244 |
|
|
2024
Q1 | $2.31M | Buy |
42,538
+2,773
| +7% | +$150K | 0.37% | 60 |
|
|
2023
Q4 | $2.04M | Buy |
39,765
+1,316
| +3% | +$67.5K | 0.38% | 62 |
|
|
2023
Q3 | $2.23M | Buy |
38,449
+13,488
| +54% | +$783K | 0.5% | 30 |
|
|
2023
Q2 | $1.6M | Buy |
24,961
+728
| +3% | +$46.6K | 0.35% | 89 |
|
|
2023
Q1 | $1.68M | Buy |
24,233
+2,476
| +11% | +$172K | 0.42% | 68 |
|
|
2022
Q4 | $1.57M | Buy |
+21,757
| New | +$1.57M | 0.44% | 67 |
|